T1	p 92 114	stable COPD patients .
T2	p 129 142	COPD patients
T3	p 596 612	60 COPD patients
T4	p 735 763	indacaterol administration .
T5	i 718 725	placebo
T6	o 623 678	dyspnea evaluation ( VAS score ) and pulmonary function
T7	o 901 938	of intrathoracic gas volume ( ?ITGV )
T8	o 964 987	residual volume ( ?RV )
T9	o 1172 1177	?ITGV